Intervention group | No. of trials | I2 | p(I2) | MD | 95% CI | p |
---|---|---|---|---|---|---|
All group | 34 | 67.851% | < 0.001 | − 1.132 | − 1.500, − 0.764 | < 0.001 |
All group* | 25 | 0.000% | 0.609 | − 0.448 | − 0.641, − 0.255 | < 0.001 |
OPTS | 15 | 76.900% | < 0.001 | − 1.486 | − 2.139, − 0.833 | < 0.001 |
OPTS* | 11 | 5.700% | 0.389 | − 0.681 | − 0.964, − 0.399 | < 0.001 |
PCPS | 15 | 40.524% | 0.035 | − 0.682 | − 1.052, − 0.312 | < 0.001 |
PCPS* | 11 | 0.000% | 0.894 | − 0.226 | − 0.499, 0.048 | 0.106 |
WS | 5 | 41.281% | 0.146 | − 1.255 | − 2.757, 0.246 | 0.101 |
WS* | 3 | 0.000% | 0.535 | − 0.490 | − 1.474, 0.493 | 0.328 |